1887

Abstract

We report on a restriction fragment-length polymorphism (CH4III) assay for profile analysis of 23S rRNA gene A2058T-mutated alleles associated with high-level macrolide resistance in . Our assay results were supported by DNA sequencing analysis, allowed for simultaneous testing of many strains, and produced results from pure-cultured colonies within 4 h.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.000130
2015-09-01
2019-10-23
Loading full text...

Full text loading...

/deliver/fulltext/jmm/64/9/990.html?itemId=/content/journal/jmm/10.1099/jmm.0.000130&mimeType=html&fmt=ahah

References

  1. Coco A., Vernacchio L., Horst M., Anderson A.. ( 2010;). Management of acute otitis media after publication of the 2004 AAP and AAFP clinical practice guideline. Pediatrics 125: 214–220 [CrossRef] [PubMed].
    [Google Scholar]
  2. Debets-Ossenkopp Y. J., Brinkman A. B., Kuipers E. J., Vandenbroucke-Grauls C. M., Kusters J. G.. ( 1998;). Explaining the bias in the 23S rRNA gene mutations associated with clarithromycin resistance in clinical isolates of Helicobacter pylori. Antimicrob Agents Chemother 42: 2749–2751 [PubMed].
    [Google Scholar]
  3. Iwata S., Sato Y., Toyonaga Y., Hanaki H., Sunakawa K.. ( 2015;). Genetic analysis of a pediatric clinical isolate of Moraxella catarrhalis with resistance to macrolides and quinolones. J Infect Chemother 21: 308–311 [CrossRef] [PubMed].
    [Google Scholar]
  4. Kasai A., Ogihara S., Yamada K., Tanimichi Y., Nishiyama H., Saito R.. ( 2015;). Prevalence and molecular analysis of macrolide-resistant Moraxella catarrhalis clinical isolates in Japan, following emergence of the highly macrolide-resistant strain NSH1 in 2011. J Med Microbiol [Epub ahead of print]. [CrossRef] [PubMed].
    [Google Scholar]
  5. Liu Y., Zhao C., Zhang F., Chen H., Chen M., Wang H.. ( 2012;). High prevalence and molecular analysis of macrolide-nonsusceptible Moraxella catarrhalis isolated from nasopharynx of healthy children in China. Microb Drug Resist 18: 417–426 [CrossRef] [PubMed].
    [Google Scholar]
  6. Ng L. K., Martin I., Liu G., Bryden L.. ( 2002;). Mutation in 23S rRNA associated with macrolide resistance in Neisseria gonorrhoeae. Antimicrob Agents Chemother 46: 3020–3025 [CrossRef] [PubMed].
    [Google Scholar]
  7. Saito R., Nonaka S., Nishiyama H., Okamura N.. ( 2012;). Molecular mechanism of macrolide-lincosamide resistance in Moraxella catarrhalis. J Med Microbiol 61: 1435–1438 [CrossRef] [PubMed].
    [Google Scholar]
  8. Seemungal T. A. R., Wilkinson T. M. A., Hurst J. R., Perera W. R., Sapsford R. J., Wedzicha J. A.. ( 2008;). Long-term erythromycin therapy is associated with decreased chronic obstructive pulmonary disease exacerbations. Am J Respir Crit Care Med 178: 1139–1147 [CrossRef] [PubMed].
    [Google Scholar]
  9. Tait-Kamradt A., Davies T., Cronan M., Jacobs M. R., Appelbaum P. C., Sutcliffe J.. ( 2000;). Mutations in 23S rRNA and ribosomal protein L4 account for resistance in pneumococcal strains selected in vitro by macrolide passage. Antimicrob Agents Chemother 44: 2118–2125 [CrossRef] [PubMed].
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.000130
Loading
/content/journal/jmm/10.1099/jmm.0.000130
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error